News | Cardiac Imaging | August 28, 2019

3D MRI computing can measure strain in the heart using image registration method without gadolinium

Displacement comparison at the end-systolic frame and final frame

Displacement comparison at the end-systolic frame and final frame. The three patients (V6, V10, V16) with different left-ventricle walls are shown. Point-to-surface distance is a measure to estimate the distance of a point from the reference surface. Image courtesy of WMG, University of Warwick

August 28, 2019 — A new 3-D magnetic resonance imaging (MRI) computing technique developed by scientists in WMG at the University of Warwick focuses on hierarchical template matching (HTM) to diagnose cardiac disease without the use of gadolinium contrast. The technique is explored in an article in the journal Scientific Reports.1

MRI has long been used to diagnose cardiomyopathy, heart attacks, irregular heartbeats and other heart disease. Traditionally when a patient goes for an MRI scan they are given a dose of gadolinium, which reacts with the magnetic field of the scanner to produce an image of the protons in the metal realigning with the field. The faster the protons realign, the brighter the image features to show where the dead muscles are in the heart and what the diagnosis is. 

The dose of gadolinium, however, can have detrimental effects to other parts of the body, particularly the risk of kidney failure. 

The hierarchical template matching technique involves:

  • A numerically stable technique of left ventricular (LV) myocardial tracking;

  • A 3-D extension of local weighted mean function to transform MRI pixels; and

  • A 3-D extension of the HTM model for myocardial tracking problems.

Use of this technique eliminates the need for gadolinium, reducing the risk of damage to other organs. 

Prof. Mark Williams from WMG at the University of Warwick said, “Using 3D MRI computing technique we can see in more depth what is happening to the heart, more precisely to each heart muscle, and diagnose any issues such as remodeling of the heart that causes heart failure. The new method avoids the risk of damaging the kidney opposite to what traditional methods do by using gadolinium.” 

Jayendra Bhalodiya, who conducted the research from WMG, University of Warwick added, “This new MRI technique also takes away stress from the patient, as during an MRI the patient must be very still in a very enclosed environment, meaning some people suffer from claustrophobia and have to stop the scan. Often when they do this they have to administer another dose of the damaging gadolinium and start again. This technique doesn’t require a dosage of anything, as it tracks the heart naturally.”

For more information:

Related Content

FDA Approves Bayer's Gadavist Contrast for Cardiac MRI in Adult Coronary Artery Disease Patients

Using Artificial Intelligence to Reduce Gadolinium Contrast

The Debate Over Gadolinium MRI Contrast Toxicity


1. Bhalodiya J.M., Palit A., Ferrante E., et al. Hierarchical Template Matching for 3D Myocardial Tracking and Cardiac Strain Estimation. Nature Scientific Reports, published online Aug. 28, 2019.

Related Content

News | Magnetic Resonance Imaging (MRI)

February 21, 2024 — Hyperfine, Inc., a groundbreaking health technology company that has redefined brain imaging with ...

Time February 21, 2024
News | Computed Tomography (CT)

February 20, 2024 — Ultrahigh-spatial-resolution photon-counting detector CT improved assessment of coronary artery ...

Time February 20, 2024
News | Cardiac Imaging

February 12, 2024 — According to the American Journal of Roentgenology (AJR), free-breathing cine-deep learning (DL) may ...

Time February 12, 2024
Videos | RSNA

At RSNA23, Imaging Technology News (ITN) spoke with Bhvita Jani, principal analyst at Signify Research, about ...

Time February 07, 2024
News | SNMMI

February 6, 2024 — The Society of Nuclear Medicine and Molecular Imaging (SNMMI) held its 2024 SNMMI Mid-Winter Meeting ...

Time February 06, 2024
News | Radiology Business

January 25, 2024 — Esaote Group, a leading Italian innovator in medical imaging, today unveiled its new brand identity ...

Time January 25, 2024
News | Artificial Intelligence

January 23, 2024 — Quibim announced it has added an industry-leading cancer detection capability to its prostate tool ...

Time January 22, 2024
Feature | Contrast Media Injectors | By Christine Book

Contrast media injectors are used to inject contrast media or contrast agents to enhance the blood and perfusion in ...

Time January 17, 2024
News | Interventional Radiology

January 10, 2024 — Proceedings from an expert consensus roundtable that discussed the benefits of intravascular ...

Time January 10, 2024
News | Magnetic Resonance Imaging (MRI)

January 9, 2024 — Hyperfine, Inc., a medical device company that has redefined brain imaging with the world’s first FDA ...

Time January 09, 2024
Subscribe Now